1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-24-293

PAR-24-293National Institutes of HealthUG3

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Oct 1, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

The purpose of this Notice of Funding Opportunity (NOFO) is to provide funding, resources, and expertise to accelerate the development of diverse biotherapeutic modalities — including but not limited to antibodies, peptides, proteins, oligonucleotides, gene therapies, cell therapies, and other emerging therapeutic modalities — for the…

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-188National Institutes of Health3 review criteria on file

$500k

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

PAR-25-062National Institutes of Health6 review criteria on file

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Genomics), with at least two weeks to apply.

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002National Institutes of Health4 review criteria on fileagency framework

$300k

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

PAR-25-370National Institutes of Health3 review criteria on fileagency framework

$50k

Everything open tagged Genomics

Hiring in this research area now

All drug discovery jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-24-293.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.